The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-2149|22|3|565-571

ISSN： 1090-3801

Source： EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol.22, Iss.3, 2018-03, pp. : 565-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 254-258

Karger

Access to resources Recommend Favorite

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 560-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 9, 2015-08 ,pp. : 1088-1096

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials

By  

Oncology Research and Treatment, Vol. 39, Iss. 7-8, 2016-06 ,pp. : 453-459

Karger

Access to resources Recommend Favorite